Researchers in China give hope for a potential vaccine against SARS-CoV-2.
Potential vaccines against COVID-19 on trial in UK and Germany
The two countries, in separate studies, begin human trials of potential vaccines against COVID-19.
Vaccine candidate against COVID-19 shows early promise
Potential vaccine against COVID-19 could begin human trials after FDA approval.
Virus-scanning tool could detect previous COVID-19 infections and aid in vaccine development
SARS-CoV-2 is being added to VirScan’s library, a virus scanning tool that can identify thousands of past and present pathogens in a single drop of blood.
NIH clinical trial of investigational vaccine for COVID-19 begins
NIH clinical trial tests a new vaccine for COVID-19 in humans. While still in early stages, the team hopes to make it available as soon as possible.
Single HPV vaccine dose may be effective against cervical cancer
New research published in CANCER indicates that a single dose of the human papillomavirus (HPV) vaccine is as effective as multiple doses for preventing preinvasive cervical disease, which can later develop into cervical cancer.
Toward a Universal Influenza Vaccine
Gilbert X. Gonzalez tells how his lab are working on influenza vaccines that can overcome the problems of the seasonal influenza vaccine.
A Universal Influenza Nanovaccine to Block Infection from Pigs
Researchers in China develop a novel vaccine that could pave the way to preventing cross-species transmission of influenza A.
Syringe-Free: Oral Vaccine against Helicobacter pylori
To fight antibiotic-resistant pathogens, and to ensure wide-spread application and high compliance, oral vaccinations are desirable, but pose drug delivery complications. An efficient nanoparticle system for vaccination against stomach ulcer causing Helicobacter pylori was recently reported.
New DNA Vaccine Enhances Protection Against Hepatitis C Virus
Researchers develop a highly effective DNA vaccine based on oscillating plasmonic gold nanoparticles for protection against the hepatitis C virus.